The United Kingdom is witnessing a remarkable evolution in its perception towards entheogens. What began with a subtle exploration of ‘shrooms’ and commonplace Ayahuasca is now broadening to feature novel substances like copyright and even investigations into clinical uses. This developing interest is driven by growing research-backed evidence